Can Investors Earn Returns and End Cancer?

One in five people worldwide will develop cancer before age 75. In the U.S., nearly $7 billion per year is spent on cancer research, and that total is expected to rise. Investment opportunities exist in immunotherapy, cell therapy, vaccines and other technologies. Private sector and government investment together will lead to world-changing therapies, meaning there is definite upside for investors. How can institutional asset owners capitalize on these opportunities? Asset owners, managers and advisers will discuss where to watch for investible insights.